Opening subject page...
Loading your content
Master the drug information hierarchy that pharmacists use to deliver evidence-based patient care.
The practice of pharmacy has always relied on accurate, accessible drug information to guide clinical decisions. In the early twentieth century, pharmacists depended almost exclusively on manufacturer-provided package inserts and a limited number of pharmacopoeias. As the pharmaceutical landscape expanded—with thousands of new molecular entities reaching the market after World War II—this ad hoc approach to information retrieval became untenable. Clinicians needed systematically organized, peer-reviewed resources that could be consulted quickly at the point of care. The classification of drug information into primary, secondary, and tertiary literature emerged to address this challenge, creating a hierarchical framework that remains fundamental to evidence-based pharmacy practice.
Understanding how drug information is categorized and where to look first is not merely an academic exercise; it is a core competency tested on the NAPLEX. A pharmacist who cannot distinguish between an indexing database and a comprehensive textbook risks providing outdated, incomplete, or poorly evaluated clinical guidance. The sections that follow systematically define secondary and tertiary resources, illustrate their applications, and prepare you for both exam questions and real-world drug information consultations.
Before examining secondary and tertiary resources in depth, it is essential to understand the broader hierarchy of drug information literature. Primary literature consists of original research reports—randomized controlled trials, cohort studies, case reports—published in peer-reviewed journals. Secondary literature refers to indexing and abstracting services that catalog primary literature so users can locate relevant studies efficiently. Tertiary literature encompasses textbooks, compendia, review articles, and point-of-care databases that synthesize and summarize information from primary and secondary sources. Each tier serves a distinct purpose, and effective drug information practice requires fluency in navigating all three.
Notice in the diagram that the width of each tier reflects the breadth of access and synthesis. Primary literature is narrow because each article addresses a specific research question and requires critical appraisal skills to interpret. Secondary resources are broader because a single database indexes millions of articles across disciplines. Tertiary resources occupy the widest band because they aggregate and interpret large bodies of evidence into clinically actionable recommendations. The annotations on the right remind us of the fundamental trade-off: as we move from primary to tertiary, we gain convenience and interpretation but risk losing currency and specificity.
Secondary resources function as sophisticated cataloging systems for the biomedical literature. They do not produce or evaluate new data; rather, they systematically index journal articles, conference abstracts, and sometimes dissertations using controlled vocabulary terms—such as Medical Subject Headings (MeSH) in PubMed—allowing clinicians to perform targeted searches. The power of a secondary resource lies in its search specificity and sensitivity: a well-constructed search strategy can retrieve virtually all relevant primary studies on a topic while minimizing irrelevant noise.
Tertiary resources compile, synthesize, and often evaluate the primary literature into accessible formats. When a pharmacist needs to quickly verify a drug's dosing, contraindications, or interactions, a tertiary resource is the appropriate first stop. The hallmark of a high-quality tertiary resource is that its content undergoes editorial review, cites primary sources, and is updated on a regular cycle. It is critical to recognize that not all tertiary resources are created equal: a continuously updated digital database like Lexicomp may reflect newer evidence than a textbook published three years ago.
Effective drug information practice requires knowing not just what secondary and tertiary resources exist, but which resource best answers a particular type of clinical question. Pharmacy educators often frame this as matching the question category to the optimal resource. The following diagram and table illustrate this mapping across the most commonly tested clinical question types.
| Resource Name | Type | Best For | Update Frequency |
|---|---|---|---|
| PubMed / MEDLINE | Secondary | Locating primary literature on any biomedical topic | Daily (new citations) |
| Embase | Secondary | European literature, pharmacology, drug safety | Daily |
| IPA | Secondary | Pharmacy practice–specific literature | Weekly / Biweekly |
| Lexicomp | Tertiary | Dosing, ADRs, interactions, patient education | Continuously |
| Micromedex | Tertiary | Evidence-rated drug evaluations, toxicology | Continuously |
| AHFS DI | Tertiary | Comprehensive monographs, off-label use support | Quarterly supplements |
| Facts & Comparisons | Tertiary | Therapeutic class comparisons | Monthly |
| Trissel's Handbook | Tertiary | IV compatibility / incompatibility data | Every 2–3 years (print); continuous (online) |
Consider the following clinical scenario: A physician contacts the pharmacy asking whether there is evidence supporting the use of metformin in patients with heart failure with preserved ejection fraction (HFpEF). She wants to know the recommended dose and whether any recent randomized controlled trials have been published. Walk through the systematic approach to answering this multifaceted question.
No single resource is perfect for every clinical scenario. Understanding the inherent strengths and limitations of secondary and tertiary literature empowers pharmacists to select the right tool for the job and to recognize when multiple resources should be consulted to triangulate an answer.
| Attribute | Secondary Resources | Tertiary Resources |
|---|---|---|
| Currency | Highly current; new citations indexed daily | Variable; digital databases are updated continuously, but textbooks may lag by 1–5 years |
| Interpretation | No interpretation; user must critically appraise retrieved articles | Information is synthesized and often graded for quality of evidence |
| Ease of Use | Requires search strategy skills (MeSH, Boolean operators) | Generally user-friendly; browse by drug name or therapeutic class |
| Scope | Broad—covers all biomedical literature in indexed journals | Focused—curated selection of clinically relevant information |
| Bias Risk | Publication bias (positive results overrepresented); language bias | Author/editor bias in selecting and interpreting studies |
| Best Use Case | Locating specific studies for in-depth clinical questions | Quick background answers at the point of care |
Mastery of secondary and tertiary resources is not an end in itself; it is the foundation of evidence-based medicine (EBM) in pharmacy practice. The EBM framework requires clinicians to integrate the best available evidence with clinical expertise and patient values. Without the ability to efficiently retrieve and evaluate evidence from the appropriate tier of literature, a pharmacist cannot fully practice within this framework. Drug Information (DI) centers—whether hospital-based or academic—operationalize these skills daily, fielding clinical questions from physicians, nurses, and other pharmacists.
| Concept | Secondary & Tertiary Resources | Advanced EBM Integration |
|---|---|---|
| Question Formulation | Classify as background vs. foreground to select resource tier | Use PICO framework (Patient, Intervention, Comparison, Outcome) to structure foreground questions for secondary database searches |
| Search Strategy | Boolean operators, MeSH terms, database filters | Systematic review methodology with PRISMA reporting; sensitivity analysis of search strategies |
| Critical Appraisal | Recognize that tertiary sources pre-evaluate evidence; secondary sources do not | Apply validated appraisal tools (Jadad scale, Cochrane Risk of Bias tool) to primary studies retrieved via secondary databases |
| Application | Answer clinical questions at the point of care | Contribute to formulary decisions, develop institutional clinical guidelines, publish DI consults |
Looking ahead, the integration of artificial intelligence into drug information retrieval is already reshaping how pharmacists interact with both secondary and tertiary resources. Natural language processing enables more intuitive searches in databases like PubMed, while AI-powered clinical decision support systems synthesize tertiary-level recommendations in real time. However, the fundamental skills covered in this lesson—knowing which resource to consult, understanding its strengths and limitations, and critically evaluating the information retrieved—remain essential regardless of technological advances. The NAPLEX tests these foundational competencies because they underpin safe, effective, and evidence-based patient care.
Drug information literature is organized into a three-tier hierarchy essential for pharmacy practice. Primary literature (original research) forms the evidentiary foundation. Secondary resources such as PubMed/MEDLINE, Embase, and International Pharmaceutical Abstracts are indexing and abstracting services that catalog primary literature without evaluating it, enabling efficient retrieval through controlled vocabulary and Boolean search strategies. Tertiary resources including Lexicomp, Micromedex, AHFS Drug Information, and Facts & Comparisons synthesize and interpret primary data into clinically actionable information, making them the first stop for routine background questions such as dosing, adverse effects, and drug interactions.
The key to effective drug information practice is matching the question type to the appropriate resource tier. Pharmacists begin with tertiary resources for quick answers and escalate to secondary databases when searching for specific primary studies to address foreground questions requiring current evidence. Understanding the strengths and limitations of each resource—including currency, bias, and ease of use—is a core competency tested on the NAPLEX and practiced daily in clinical pharmacy settings.